⾕
Antibody Structure — Domains, Isotypes, & Clinical Relevance | BaileyGwyn.xyz

Antibody Structure — Domains, Isotypes, & Clinical Relevance

Antibodies (immunoglobulins) are Y-shaped glycoproteins made of two heavy and two light chains. Their Fab regions bind antigen via CDRs; Fc regions engage immune effectors (Fc receptors, complement). Structure underlies neutralization, opsonization, complement activation, and clinical uses of monoclonals.

Skip to content

🧬 Antibody Structure

Antibody Structure — Domains, Isotypes, & Clinical Relevance

Antibodies (immunoglobulins, Ig) are central to adaptive immunity. Their **structure** explains their **function**—from precise antigen recognition to effector activation. Here’s a deep dive into domains, isotypes, binding chemistry, and why architecture matters in diagnostics and therapeutics.

Types of antibodies (IgG, IgA, IgM, IgE, IgD) showing monomer, dimer, and pentamer structures with J chain and secretory component
Isotypes at a glance: IgG (monomer), IgA (dimer with J chain and secretory component), IgM (pentamer with J chain), IgE and IgD (monomers).

1) Overview & Core Functions

Key effector roles include neutralization (block toxins/viruses), opsonization (tag for phagocytes), complement activation (classical pathway), and agglutination (clumping to aid clearance). These roles depend on modular domains that couple **specific recognition** to **immune activation**.

2) Quaternary Architecture & Domains

2.1 Chains & Disulfides

  • Two heavy (H) chains (~50 kDa each) + two light (L) chains (~25 kDa each).
  • Inter- and intrachain disulfide bonds stabilize the Y-shaped heterotetramer.
  • Each chain comprises repeating immunoglobulin folds (β-sandwich domains).

2.2 Fab vs Fc

  • Fab (antigen-binding): Variable (V) + Constant (C) domains from H and L chains; contains CDR1–3 loops that form the paratope.
  • Fc (crystallizable): Heavy-chain constant domains (e.g., CH2–CH3) that engage Fc receptors and complement.
  • Hinge: Flexible linker between Fab and Fc, increasing angular reach and avidity; prominent in IgG/IgA.

2.3 Variable Regions, CDRs, and Specificity

  • CDRs are hypervariable loops within VH and VL that determine specificity and affinity for an epitope (linear or conformational).
  • Paratope–epitope binding uses noncovalent forces (H-bonds, electrostatic, van der Waals, hydrophobic).
  • Affinity (single site) vs avidity (combined binding across sites; high in IgM pentamers and IgA dimers).

2.4 Glycosylation

  • IgG Fc typically carries an N-linked glycan (classically near Asn297), modulating Fc receptor binding and complement engagement.
  • Glycan composition can tune effector function (e.g., ADCC potency via FcγRIIIa interactions).

3) Isotypes & Subclasses

Heavy chain class (γ, α, μ, ε, δ) defines the five major isotypes; each has characteristic **Fc** structure and effector profile.

IgG (γ) — Monomer

  • ~75–80% of serum Ig; versatile: neutralization, opsonization, complement.
  • Placental transfer via FcRn provides neonatal passive immunity.
  • Subclasses: IgG1–IgG4 (varying hinge length and effector strength).

IgA (α) — Dimer (secretory)

  • Dominant at mucosae (tears, saliva, breast milk); forms secretory IgA with a J chain and secretory component.
  • Subclasses: IgA1/IgA2 (hinge length differences influence protease sensitivity).

IgM (μ) — Pentamer

  • First isotype produced; high avidity, potent in classical complement activation.
  • Contains a J chain aiding polymerization and mucosal transport.

IgE (ε) — Monomer

  • Binds high-affinity FcεRI on mast cells/basophils; allergy (histamine release) and anti-parasite roles.

IgD (δ) — Monomer

  • Expressed with IgM on naive B cell surfaces; contributes to BCR signaling/activation.

4) Effector Coupling: Receptors & Complement

Fc Receptors (FcRs)

  • FcγR (for IgG) on macrophages, NK cells: drive ADCP/ADCC; subclasses differ in affinity.
  • FcαRI (for IgA) on myeloid cells: mucosal opsonophagocytosis.
  • FcεRI (for IgE) on mast cells/basophils: degranulation upon cross-linking.

Neonatal Fc Receptor (FcRn)

  • Transports IgG across placenta; in adults, recycles IgG to extend half-life (endosomal salvage).

Complement (Classical Pathway)

  • IgG and IgM Fc regions bind C1q to initiate the cascade → opsonization (C3b), inflammation, lysis.

5) Antigen Binding Chemistry

  • Noncovalent forces: hydrogen bonds, electrostatic interactions, van der Waals, hydrophobic contacts.
  • Epitope types: linear (sequence) vs conformational (3D structure).
  • Idiotype (unique variable-region determinants), allotype (allelic constant-region variants), isotype (class/subclass).

6) B Cell Expression & Diversification

BCR vs Secreted Ig

  • Membrane BCR includes a tailpiece/transmembrane region for signaling (with Igα/Igβ).
  • Plasma cells produce secreted antibodies lacking the transmembrane segment.

V(D)J, SHM, CSR (AID-dependent)

  • V(D)J recombination builds primary repertoire (combinatorial & junctional diversity).
  • Somatic hypermutation (SHM) + selection → affinity maturation.
  • Class-switch recombination (CSR) changes isotype (μ/δ → γ/α/ε) without altering specificity.

7) Clinical & Biotech Applications

  • Monoclonal antibodies (mAbs): oncology (e.g., anti-CD20, anti-HER2), autoimmune disease (e.g., anti-TNF), infectious disease neutralizers.
  • Diagnostics: ELISA, Western blot, lateral-flow assays.
  • Passive immunity: convalescent plasma; therapeutic neutralizing mAbs.
  • Engineering: Fc glyco-/protein engineering to tune half-life, ADCC, and complement activity.
Structure is not academic trivia—**CDRs, hinge, Fc glycan, and isotype** choices directly determine clinical behavior (potency, half-life, safety).
💠 Explore Topics 📚 Read FAQs